Interrelationship of Serum HER2-ECD with Pathological HER2 level (Human Epidermal Growth Factor Receptor Type2 - Extra Cellular Domain) in Operable Gastric Cancer Patients in Japa
Not Applicable
Recruiting
- Conditions
- Gastric Cancer
- Registration Number
- JPRN-UMIN000006048
- Lead Sponsor
- Shizuoka General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient with Breast cancer 2) Patient with active double cancer (synchronous double cancer and metachronous double cancer), excluding carcinoma in situ (lesions equal to intraepithelial or intramucosal cancer) judged to have been cured with local treatment. 3) Patient with severe complications, such as paralytic ileus, bowel obstruction, interstitial pneumonitis, pulmonary fibrosis, or uncontrollable diabetes mellitus, arrhythmias, heart failure, liver cirrhosis, and active hepatitis) 4) Exclude the patients who are recognized as inadequate patients by doctors with responsibility in this trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Interrelationship of serum HER2-ECD with pathological HER2 level.
- Secondary Outcome Measures
Name Time Method